首页ACUR • OTCMKTS
add
Acura Pharmaceuticals Inc
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2021info | 年同比变化 |
|---|---|---|
收入 | 156.30万 | -56.22% |
经营支出 | 125.30万 | -33.32% |
净收入 | -87.90万 | 27.24% |
净利润率 | -56.24 | -66.19% |
每股收益 | — | — |
息税折旧摊销前利润 | -114.10万 | -3,360.00% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2021info | 年同比变化 |
|---|---|---|
现金及短期投资 | 6.50万 | -84.26% |
总资产 | 86.00万 | -50.46% |
负债总额 | 68.20万 | -91.06% |
权益总额 | 17.80万 | — |
发行在外的股份 | 6600.18万 | — |
市净率 | ∞ | — |
资产回报率 | -58.46% | — |
资本回报率 | -200.73% | — |
现金流
现金净变动
| (USD) | 2021info | 年同比变化 |
|---|---|---|
净收入 | -87.90万 | 27.24% |
来自运营的现金 | -74.20万 | -3.20% |
投资现金 | — | — |
融资现金 | 39.40万 | 45.93% |
现金净变动 | -34.80万 | 22.49% |
自由现金流 | -110.08万 | -238.17% |
简介
Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR". Wikipedia
成立时间
1935
员工数量
9
